AU4934499A - Therapeutic agent for dementia, comprising ginseng extract - Google Patents

Therapeutic agent for dementia, comprising ginseng extract

Info

Publication number
AU4934499A
AU4934499A AU49344/99A AU4934499A AU4934499A AU 4934499 A AU4934499 A AU 4934499A AU 49344/99 A AU49344/99 A AU 49344/99A AU 4934499 A AU4934499 A AU 4934499A AU 4934499 A AU4934499 A AU 4934499A
Authority
AU
Australia
Prior art keywords
dementia
therapeutic agent
ginseng extract
ginseng
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49344/99A
Inventor
Kyoon Huh
In-Soo Joo
Min-Whan Jung
Inhee Mook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Digital Biotech Co Ltd
Original Assignee
Digital Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Digital Biotech Co Ltd filed Critical Digital Biotech Co Ltd
Publication of AU4934499A publication Critical patent/AU4934499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU49344/99A 1998-07-20 1999-07-19 Therapeutic agent for dementia, comprising ginseng extract Abandoned AU4934499A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR19980029151 1998-07-20
KR9800291 1998-07-20
KR1019990028866A KR20000006625A (en) 1998-07-20 1999-07-16 Treatment For Dementia Comprising Ginseng Extract
KR9900288 1999-07-16
PCT/KR1999/000381 WO2000004912A1 (en) 1998-07-20 1999-07-19 Therapeutic agent for dementia, comprising ginseng extract

Publications (1)

Publication Number Publication Date
AU4934499A true AU4934499A (en) 2000-02-14

Family

ID=26633931

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49344/99A Abandoned AU4934499A (en) 1998-07-20 1999-07-19 Therapeutic agent for dementia, comprising ginseng extract

Country Status (3)

Country Link
KR (1) KR20000006625A (en)
AU (1) AU4934499A (en)
WO (1) WO2000004912A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1213026A4 (en) * 1999-08-30 2004-06-16 Japan Science & Tech Agency Brain cell or nerve cell protecting agents comprising ginseng
KR100472380B1 (en) * 2001-12-18 2005-03-08 나승열 Preventive and therapeutic composition against kainic acid-induced neurotoxicity in hippocampus containing ginsenosides
DE10213571A1 (en) * 2002-03-26 2003-10-23 Lichtwer Pharma Ag Plant extracts and their application
KR100452555B1 (en) * 2004-07-15 2004-10-13 박용진 A composition comprising purified extract of wild ginseng having neuronal cell-protecting activity
EP1846011B1 (en) 2005-01-25 2011-08-24 Neumed Inc. Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke
US7884195B2 (en) 2005-04-26 2011-02-08 Long Yun Li Method of extracting ginsengnoside Rg2m, pharmaceutical composition including ginsengnoside Rg2, and uses thereof
KR100804480B1 (en) * 2006-04-27 2008-02-20 한국과학기술연구원 A composition for improving memory
KR101917128B1 (en) * 2017-04-28 2018-11-09 강원대학교산학협력단 Pharmaceutical composition for preventing or treating Alzheimer's disease comprising mountain-cultivated ginseng extract

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966893A (en) * 1989-01-13 1990-10-30 Pang Peter K T Method for treatment of senile dementia

Also Published As

Publication number Publication date
KR20000006625A (en) 2000-02-07
WO2000004912A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AUPP337298A0 (en) Process for microgel preparation
AU7808198A (en) Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
AU1280100A (en) Novel 2-pyridone derivatives, preparation method and therapeutic use
AU2002356533A1 (en) Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
HK1052702A1 (en) Method for the preparation of 5-carboxyphthalide.
AU3826799A (en) Process for the preparation of styrenes
AU5651799A (en) Remedies for photochemotherapy
AU3028599A (en) Process for preparing styrenes
AU4934499A (en) Therapeutic agent for dementia, comprising ginseng extract
AU6015400A (en) Glycyrrhizin preparations for transmucosal absorption
HUP0104819A2 (en) Chroman derivatives, their use intermediate and process for their preparation
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
AU6866500A (en) Chromone derivatives, process for the preparation of the same and uses thereof
AU2926399A (en) Process for the preparation of styrenes
AU6997800A (en) Method for product assurance
EP1071746A4 (en) Process for preparing doxorubicin
AU4437400A (en) Method for preparing melamine
AU2214199A (en) Therapeutic liposome-encapsulated immunomodulators
AU2000241467A1 (en) Cognitive enhancer comprising ginseng extract
AU2049400A (en) Improved guidewire
AU1386400A (en) Extract
AU3837100A (en) Vitamin d derivatives and process for producing the same
ZA991786B (en) Therapeutic treatment for asthma.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase